The synthesis of new compounds with novel biological properties and functionalities to fight
emerging diseases has the significant role in pharmaceutical science. Schiff bases are the …

In the search of significant biological agents for the pathogenic causing deformities, four
bidentate heterocyclic Schiff base ligands and their sixteen Co (II), Ni (II), Cu (II) and Zn (II) …

Three prominent health challenges affecting our society include cancer, diabetes, and
antibiotic-resistant infections. Despite the availability of conventional drugs for these …

N, N′‐bis (2, 4‐dihydroxy benzaldehyde‐1, 2‐diaminobenzene)(H4L) formed from the
reaction of 2, 4‐dihydroxybenzaldehyde and 1, 2‐diaminobenzene was complexed with Cu …

Mixed ligand complexes of Cu (II), Co (II), Ni (II), Mn (II) and Cd (II) with N, N'-1, 4-phenylene
(2-hyboxynaphthaliden imine)(H 2 L) as primary ligand and 4-aminoantipyrine (4-AAp) as …

A novel bis-bidentate azo dye ligand, formed by the diazotized reaction of 1, 4-
diaminobenzene and 8-hydroxyquinoline in 1: 2 M ratio resulted the formation of 5, 5′-{(1E …

A tetra dentate ONNO donor diaminomaleonitrile-based Schiff base ligand along with its four
new complexes of Co (II), Ni (II), Cu (II), and Zn (II) have been synthesized. The …

The present study was designed to discover novel secondary antibiotic metabolites from
Actinomycetes species from the soil of Rijal Almaa, Saudi Arabia. A laboratory-scale …

Metal (II) complexes of Cu (II)(1), and Ni (II)(2) with Schiff base derived from 4‐amino‐
antipyrine were synthesized. These complexes were fully characterized by FTIR, and UV …

In recent years, metal-based compounds have been explored as potential remedies for
major health issues such as diabetes, bacterial infections, and oxidative stress, which impact …